Abstract | PURPOSE/OBJECTIVES: To describe the role of bisphosphonate therapy for metastatic bone disease and skeletal-related events associated with some of the most common malignancies, and to highlight the importance and untapped potential of nurses intervening in the education and treatment of patients with these issues. DATA SOURCES: Contemporary evidence-based studies on the prevalence and impact on quality of life in metastatic bone disease and skeletal-related events, and all major clinical trials describing the efficacy of bisphosphonates for the treatment of metastatic bone disease. DATA SYNTHESIS: CONCLUSIONS: IMPLICATIONS FOR NURSING: Nurses are uniquely positioned to educate patients and their caregivers about the need to begin or continue taking bisphosphonates for treatment of metastatic bone disease and associated skeletal-related events. Nurses often are the most appropriate healthcare providers for counseling patients with metastatic cancer about personal and family issues and for communicating the needs and concerns of patients to their physicians.
|
Authors | Margaret I Fitch, Cathy Maxwell |
Journal | Oncology nursing forum
(Oncol Nurs Forum)
Vol. 35
Issue 4
Pg. 709-13
(Jul 2008)
ISSN: 1538-0688 [Electronic] United States |
PMID | 18591175
(Publication Type: Journal Article, Review)
|
Chemical References |
- Bone Density Conservation Agents
- Diphosphonates
|
Topics |
- Bone Density Conservation Agents
(therapeutic use)
- Bone Neoplasms
(psychology, secondary, therapy)
- Communication
- Diphosphonates
(therapeutic use)
- Health Services Needs and Demand
- Humans
- Nurse's Role
(psychology)
- Nurse-Patient Relations
- Oncology Nursing
(organization & administration)
- Patient Compliance
(psychology)
- Patient Education as Topic
(organization & administration)
- Practice Guidelines as Topic
- Quality of Life
(psychology)
- Treatment Outcome
- Trust
|